Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06598436 · ClinicalTrials.gov registry record · NA
Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
A NA study of Diabetes, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06598436: Recruiting NA study of Diabetes, sponsored by University of California, San Francisco.
NCT06598436 is a NA study of Diabetes that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 600 participants, below the 3,026-participant average among 338 other Diabetes trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06598436, a NA study of Diabetes, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the impact of a multi-level intervention aiming to improve telehealth access for low-income patients managing chronic health conditions, such as hypertension and diabetes. The multi-level intervention includes clinic-level practice facilitation and patient-level digital health coaching.
Primary Outcome
Change in A1C (%) will be determined by subtracting month 3, 6, and 12 A1C values from baseline A1C
Conditions Studied
Interventions
- OTHER Digital Health Coaching (Patient-Level Intervention)
- OTHER Practice Facilitation (Clinic-Level Intervention)
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital (ZSFG) & SF Department of Public Health (DPH) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT06598436 shows while recruiting
NCT06598436 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 3,026-participant average among 338 other Diabetes trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Digital Health Coaching (Patient-Level Intervention) is the first listed.
NCT06598436 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06598436 about?
NCT06598436 is a clinical study titled "Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem". This study examines the impact of a multi-level intervention aiming to improve telehealth access for low-income patients managing chronic health conditions, such as hypertension and diabetes. The multi-level intervention includes clinic-level practice facilitation and patient-level digital health co...
What is the current status of trial NCT06598436?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-11-04. Estimated completion is 2028-09.
What conditions does trial NCT06598436 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT06598436?
The interventions under investigation include: Digital Health Coaching (Patient-Level Intervention) (OTHER), Practice Facilitation (Clinic-Level Intervention) (OTHER).
Who is sponsoring clinical trial NCT06598436?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06598436 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06598436's enrollment target sits among peer trials
600 65th of 338 higher than 273 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI